Biora Therapeutics, Inc. (BIOR)
(Delayed Data from NSDQ)
$0.66 USD
+0.03 (5.29%)
Updated Apr 30, 2024 04:00 PM ET
After-Market: $0.66 0.00 (0.70%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMDetailed Estimates
EPS Estimates
Exp Earnings Date | 5/20/24 |
---|---|
Current Quarter | -0.45 |
EPS Last Quarter | -0.63 |
Last EPS Surprise | -5.00% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -1.46 |
Next Year | -1.27 |
EPS (TTM) | -4.44 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | 5.00M |
# of Estimates | NA | NA | NA | 1 |
High Estimate | NA | NA | NA | 5.00M |
Low Estimate | NA | NA | NA | 5.00M |
Year ago Sales | 0.00M | 0.00M | 0.00M | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.45 | -0.46 | -1.46 | -1.27 |
# of Estimates | 1 | 1 | 2 | 2 |
Most Recent Consensus | -0.45 | -0.46 | -1.92 | -1.61 |
High Estimate | -0.45 | -0.46 | -1.00 | -0.93 |
Low Estimate | -0.45 | -0.46 | -1.92 | -1.61 |
Year ago EPS | -1.59 | -1.47 | -7.88 | -1.46 |
Year over Year Growth Est. | 71.70% | 68.71% | 81.47% | 13.01% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 1 | 1 |
Up Last 60 Days | 0 | 0 | 1 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.45 | -0.46 | -1.46 | -1.27 |
7 Days Ago | -0.45 | -0.46 | -1.46 | -1.27 |
30 Days Ago | NA | NA | -2.06 | -2.01 |
60 Days Ago | NA | NA | -2.06 | -2.01 |
90 Days Ago | NA | NA | -2.06 | -2.01 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.45 | -0.46 | -1.92 | -1.61 |
Zacks Consensus Estimate | -0.45 | -0.46 | -1.46 | -1.27 |
Earnings ESP | 0.00% | 0.00% | -31.51% | -26.77% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.63 | -0.75 | -1.47 | -1.59 | NA |
Estimate | -0.60 | -0.93 | -1.60 | NA | NA |
Difference | -0.03 | 0.18 | 0.13 | NA | 0.09 |
Surprise | -5.00% | 19.35% | 8.13% | NA | 7.49% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more